Beyond Stronger Glasses: The AMA Formally Backs Classifying Myopia as a Disease

For decades, nearsightedness (myopia) was treated as a routine optical inconvenience—a minor nuisance managed with a trips to the optometrist and progressively thicker lenses every school year. However, in a landmark policy shift, the American Medical Association (AMA) backed a formal resolution calling for the classification of nearsightedness as a disease, urging recognition from regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS).

This move directly aligns with a global initiative launched by the American Academy of Ophthalmology (AAO) to transform myopia management from reactive vision correction into proactive disease prevention.

Why Is Myopia More Than Just a Refractive Error?

Myopia is caused by axial elongation—the progressive stretching and lengthening of the eyeball from front to back. As the eye grows unnaturally long, the light coming into the eye focuses in front of the retina rather than directly on it, blurring distance vision.

The primary health concern is not just the prescription power, but the physical stretching of ocular tissues. Severe or "high" myopia significantly increases a person's lifetime risk for sight-threatening eye conditions, including:

• Retinal Detachment: The retina stretches thin and can tear or detach from the back of the eye.

• Glaucoma: Increased vulnerability to optic nerve damage.

• Myopic Maculopathy: Progressive damage to the central retina, leading to irreversible vision loss.

• Early-Onset Cataracts: Premature clouding of the eye's natural lens.

The Public Health Reality: A Growing Global Epidemic

The AMA's endorsement comes amidst a dramatic spike in myopia cases nationwide and globally.

Mention Orthokeratology (Ortho-K) to most people, and they immediately may never have heard this kind of unique contact lens or people may picture children using it. It is widely known as the go-to treatment for slowing down nearsightedness in kids.